KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $10.7 million.

  • Idexx Laboratories' Interest Expenses rose 3843.06% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year increase of 1264.1%. This contributed to the annual value of $31.2 million for FY2024, which is 2495.37% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Interest Expenses is $10.7 million, which was up 3843.06% from $11.3 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Interest Expenses high stood at $13.5 million for Q4 2022, and its period low was $7.0 million during Q1 2022.
  • In the last 5 years, Idexx Laboratories' Interest Expenses had a median value of $8.1 million in 2024 and averaged $9.1 million.
  • As far as peak fluctuations go, Idexx Laboratories' Interest Expenses soared by 8763.58% in 2023, and later tumbled by 3973.49% in 2024.
  • Quarter analysis of 5 years shows Idexx Laboratories' Interest Expenses stood at $7.5 million in 2021, then soared by 81.18% to $13.5 million in 2022, then tumbled by 31.61% to $9.3 million in 2023, then dropped by 19.07% to $7.5 million in 2024, then soared by 42.1% to $10.7 million in 2025.
  • Its Interest Expenses stands at $10.7 million for Q3 2025, versus $11.3 million for Q2 2025 and $7.7 million for Q1 2025.